Clinical Trial Coordinator
About this recruitment
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry has issued an official recruitment notice for the post of Clinical Trial Coordinator at Puducherry. A total of 1 vacancy is advertised. The post sits in the Department of Nephrology department. MediJobs indexes this notice from the institution's own source and links to it; applications are made only on the official portal.
Posts advertised: Clinical Trial Coordinator (1 post).
Eligibility: B.Sc / M.Sc. or equivalent degree in Nursing or Allied Health Sciences from a recognised institution, including B.Sc / M.Sc Nursing, or a degree in any recognised allied health sciences discipline such as medical lab technology, dialysis technology, perfusion technology, Cardiac Technology, OT technology, etc., or other equivalent Allied Health Sciences Disciplines. Experience required: Preferable: One year of clinical trial experience; Computer Skills with data entry of patient-level database; Applicants with research experience, good communication skills in Tamil and basic computer skills will be preferred. Age limit: up to 30 years as stated in the notice.
Remuneration: INR 21,500/- (Consolidated). The official notice is authoritative on pay.
Candidates must apply through the official notification linked on this page. Government recruitment never charges a fee over messaging apps and never asks for payment in exchange for an offer letter.
At a glance
Roles & reservation
| Role | Total | UR | OBC | SC | ST | EWS | PwBD | Contract | Pay |
|---|---|---|---|---|---|---|---|---|---|
| Clinical Trial Coordinator — Department of Nephrology | 1 | — | — | — | — | — | — | project-based | INR 21,500/- (Consolidated) |
UR · Unreserved, OBC, SC, ST, EWS, PwBD as stated in the official notice. Verify category eligibility on the source document.
Government recruitment never asks for application fees over WhatsApp or for advance payment for an offer letter. Always apply only on the official portal linked above. Read our anti-fraud guidance.